Latest Stories

E
Three Reasons

Encompass Health (EHC): Buy, Sell, or Hold Post Q4 Earnings?

Over the last six months, Encompass Health’s shares have sunk to $109.09, producing a disappointing 10.7% loss - a stark contrast to the S&P 500’s 6.7% gain. This may have investors wondering how to approach the situation.

Feb 19, 2026
N
Three Reasons

NBT Bancorp (NBTB): Buy, Sell, or Hold Post Q4 Earnings?

NBT Bancorp trades at $44.99 per share and has stayed right on track with the overall market, gaining 6.5% over the last six months. At the same time, the S&P 500 has returned 6.7%.

Feb 19, 2026
N
Three Reasons

Nelnet (NNI): 3 Reasons We Love This Stock

Nelnet has been treading water for the past six months, recording a small return of 3.8% while holding steady at $131.52.

Feb 19, 2026
C
Three Reasons

2 Reasons to Like COST and 1 to Stay Skeptical

Costco has been treading water for the past six months, recording a small return of 1.6% while holding steady at $997. The stock also fell short of the S&P 500’s 6.7% gain during that period.

Feb 19, 2026
V
Three Reasons

3 Reasons VLY is Risky and 1 Stock to Buy Instead

Valley National Bank has had an impressive run over the past six months as its shares have beaten the S&P 500 by 27.7%. The stock now trades at $13.12, marking a 34.4% gain. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

Feb 19, 2026
G
Three Reasons

General Mills (GIS): Buy, Sell, or Hold Post Q4 Earnings?

Over the past six months, General Mills’s shares (currently trading at $45.45) have posted a disappointing 8.9% loss, well below the S&P 500’s 6.7% gain. This might have investors contemplating their next move.

Feb 19, 2026
F
Three Reasons

3 Reasons to Sell FTRE and 1 Stock to Buy Instead

Over the past six months, Fortrea has been a great trade, beating the S&P 500 by 28.1%. Its stock price has climbed to $10.64, representing a healthy 34.8% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Feb 19, 2026
S
Three Reasons

3 Reasons to Avoid SNEX and 1 Stock to Buy Instead

StoneX currently trades at $129.54 and has been a dream stock for shareholders. It’s returned 386% since February 2021, blowing past the S&P 500’s 75.1% gain. The company has also beaten the index over the past six months as its stock price is up 34.2% thanks to its solid quarterly results.

Feb 19, 2026
G
Three Reasons

3 Reasons GDEN is Risky and 1 Stock to Buy Instead

Golden Entertainment has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.1%. The stock now trades at $28.65, marking a 15.9% gain. This run-up might have investors contemplating their next move.

Feb 19, 2026
T
Three Reasons

3 Reasons to Sell TWI and 1 Stock to Buy Instead

Titan International’s 22.1% return over the past six months has outpaced the S&P 500 by 15.4%, and its stock price has climbed to $10.58 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Feb 19, 2026